Related Experiment Video
Updated: Dec 11, 2025
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
Patents in chemotherapy: nanoparticles as drug-delivery vehicles
1Medical Microbiology & Molecular Biology Lab., Interdisciplinary Biotechnology Unit, AMU, Aligarh 202002, India.
Abstract:
The high statistics of cancer cases and mortalities throughout the world signify the urgent need for an advanced technology to target tumor cells. Nanotechnology has emerged as one such revolutionary platform to specifically target cancerous tissues and to enhance the efficacy for various anticancer drugs. This report is a snapshot of the patents in chemotherapy from January 2010 to May 2020 involving nanoparticles, novel methods developed for their synthesis and their impact as efficient drug-delivery vehicles.
Insights
Nanotechnology offers advanced solutions for cancer treatment by enabling targeted delivery of chemotherapy drugs. This review highlights patents from 2010-2020 on nanoparticle synthesis and their role in enhancing drug efficacy against tumors.
Area of Science:
- Oncology and Nanomedicine: Focus on advanced cancer treatment strategies.
- Materials Science: Synthesis and characterization of novel nanoparticles for drug delivery.
Background:
- Global cancer burden necessitates innovative therapeutic approaches.
- Chemotherapy faces challenges including systemic toxicity and limited tumor targeting.
Discussion:
- Nanoparticle-based drug delivery systems show promise in overcoming chemotherapy limitations.
- Patents reveal diverse synthesis methods for nanoparticles tailored for cancer therapy.
- Evaluation of nanoparticle formulations for enhanced drug payload and controlled release.
Key Insights:
- Nanoparticles significantly improve the specificity of anticancer drug delivery to tumor sites.
- Novel synthesis techniques are crucial for developing efficient and safe nanocarriers.
- Patented technologies demonstrate the potential of nanomedicine in improving patient outcomes.
Outlook:
- Continued innovation in nanoparticle design for targeted cancer chemotherapy.
- Further research into clinical translation of nanomedicine for broader applications.
- Potential for personalized nanomedicine approaches in cancer treatment.
